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Abstract 
Autonomous self-healing in carbon fibre reinforced polymer (CFRP) is demonstrated using epoxy resin filled 
microcapsules and a solid-state catalyst. Microcapsules filled with oligomeric epoxy resin (20-450 µm) and 
particles of Sc(OTf)3 are embedded in an interleave region of a unidirectional CFRP laminate and tested under 
mode I loading. Double cantilever beam (DCB) test specimens containing variable concentrations of 
microcapsules and catalyst were prepared, tested and compared to those healed by manual injection with 
corresponding healing resin formulation. The healing efficiency was evaluated by comparing the maximum 
peak load recorded on load-displacement curves for pristine and healed specimens. A 44% maximum recovery 
was observed for specimens containing 10wt% of solid phase catalyst and 11wt% of epoxy microcapsules. 
However, a significant (80%) decrease in initial strain energy release rate (GIC) was observed for specimens 
with the embedded healing chemistries.  
 
Visual abstract  
 
Epoxy filled microcapsules with poly(urea-formaldehyde) shell wall after synthesis (left) and following fracture 
testing.   
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1. Introduction  
Fibre reinforced polymer (FRP) composites are increasingly used in industries like aerospace, energy, 
automotive and in offshore structures due to their exceptional specific mechanical properties compared to 
conventional materials (1). In service, FRPs are susceptible to internal damage, including matrix cracking, fibres 
fracture, and delamination between plies. When undetected and unrepaired, these damages can be of significant 
detriment to performance, ultimately leading to premature failure. It can be addressed by embedding 
functionality capable of effecting autonomous repair, minimising often complicated and difficult damage 
detection strategies and manual maintenance (2,3).  
Self-healing has already been widely studied in polymers and the fibre reinforced composites where 
autonomous repair has been achieved through a range of approaches (2–4) including embedding healing-agent-
filled microcapsules (5–23), hollow fibres (24–26) or incorporating vascular networks capable of delivering 
various healing chemistries (27,28). These systems are considered as extrinsic, and mean that the healing 
chemistries are introduced externally into the crack planes. Another approach described in the literature includes 
intrinsic mechanisms, where the polymer is capable of healing without any external supply of healing agent (29–
34). The most developed approach to date sees microencapsulation of a healing monomer or oligomer within a 
polymeric shell, which are then embedded in a host material. Embedded microcapsules are ruptured by a 
propagating crack to release the healing agent, upon subsequent chemical reaction or physicochemical 
processes, new polymer bonds the fracture surfaces and restores the lost material properties (2-4).  
The first and most widely exploited microencapsulation system was proposed in 2001 by White et al (5). In 
this approach, microencapsulated dicyclopentadiene (DCPD) was embedded in an epoxy polymer and 
polymerized following release in the presence of ruthenium Grubbs’ catalyst (Ring Opening Metathesis 
Polymerization - ROMP). Despite high healing efficiencies (3), the high price of the ruthenium catalyst and its 
low stability in the presence of moisture, amine hardeners and oxygen, limited its commercialization. Several 
modifications were proposed including protecting the Grubbs’ catalyst in wax or usage of alternative second 
generation, Hoveyda – Grubbs’ and Tungsten hexachloride as catalysts (6-8). However, these barriers still limit 
DCPD/Grubbs’ system wider application in autonomous healing materials. To overcome some of these issues 
and to provide a healing system that is chemically and mechanically compatible with a typical host epoxy 
matrix, less expensive Diglycidyl Ether of Bisphenol A (DGEBA) was demonstrated as an alternative healing 
agent (7-14). Encapsulated DGEBA was combined with a variety of hardeners, including catalytic curing agents 
(9,10,20) and multifunctional amines (11-14). In the most recent work, Coope et al (9) utilized scandium (III) 
triflate particles as a catalytic curing agent for an epoxy resin. A maximum of 80% of healing efficiency was 
achieved at elevated temperatures using Tapered Double Cantilever Beam (TDCB) test specimens in a low 
temperature curing epoxy (9). In other approaches, liquid phase and relatively toxic curing agents were utilised, 
such as boron trifluoride etherate hardener ((C2H5)2O·BF3) (10), epoxy/mercaptan (11, 12) and epoxy/amine 
chemistry (13, 14). Within these works, two types of capsules were utilised to successfully separate the healing 
chemistries from the surrounding environment and the healing efficiency was often dependent on stoichiometric 
ratio and contact of both healing components.  
An alternative, single capsule approach to self-healing was demonstrated in the literature and utilized the 
inherent residual functionality of the host epoxy (2-4). Healing is achieved via interaction of encapsulated 
solvent with residual functionality in the epoxy polymer. For instance, almost full recovery of mode I fracture 
toughness was demonstrated using solvent (Ethyl phenylacetate) filled microcapsules (15,16, 23). Non-fully 
cured epoxy matrix is swollen by the solvent released from microcapsules and the residual functional groups 
initiate further crosslinking which re-bond fractured surfaces. The system was modified by use of Shape 
Memory Alloys (SMA) to reduce the separation after fracture damage and to enhance the healing performance 
(17,18). However, the need for unreacted functional groups in under-cured epoxy limits the broader applications 
of this self-healing system. Other, latent functionality was also proposed by Yin et al. (19) where hardener 
dispersed in the matrix (CuBr2(2-methylimidazole)4) was available for a healing reaction, but required heating to 
130°C to polymerize the released resin. Moreover, Xiao et al. (20) studied a system using the (C2H5)2O·BF3 
catalyst absorbed by short sisal fibres and protected by a polystyrene coating.  
In this work we demonstrate an autonomous self-healing unidirectional fibre reinforced composite structure 
of commercially available epoxy resin/carbon fibre resin tape (SE 70, Gurit, UK). Self-healing was achieved by 
embedding of epoxy resin filled microcapsules (20-450 µm) and solid state catalyst (Sc(OTf)3) in a damage 
region. The main aim of this work is optimisation and assessment of the selected system as a self-healing 
function within a high performance composite structure. Microencapsulated self-healing has already been 
demonstrated in epoxy polymers and their composites with woven fibres, however, application in unidirectional 
composites is relatively unexplored. A maximum mode I DCB recovery of 42% is achieved for an autonomous 
system which is comparable to a manually initiated approach (52%). However, the high healing efficiency is 
associated with significant detrimental effect on the host polymer fracture properties. Nevertheless, it is 
demonstrated that microencapsulated self-healing can be achieved in a unidirectional composite cured at high 
temperature (100 °C) using a microcapsule – catalyst approach and that the healing functionality can be 
optimised to avoid any significant detrimental effects.  
In general, the selected epoxy resin – organic solvent system was encapsulated in a poly(urea-formaldehyde) 
shell using a standard processing technique described in the literature (21). Microcapsules and commercially 
sourced catalytic curing agent were embedded in an interleave region of a FRP laminate using standard hand 
lay-up techniques. After initial DCB tests to assess mode I strain energy release rate (GIC) recovery, the volume 
of embedded epoxy resin and catalyst loading were varied in order to assess the healing rate. Herein the effect of 
both components on the damage region is demonstrated and discussed in detail. Microcapsules containing 
Diglycidyl Ether of Bisphenol A (75wt%) and high boiling point organic solvent, ethyl phenylacetate (25wt%) 
have been documented in previous studies as an effective application of self-healing epoxides (9). Scandium 
(III) triflate (Sc(OTf)3) was selected as a suitable initiator due to its stability and catalytic activity in the 
polymerization of epoxy resins (9, 35–37). Furthermore, Sc(OTf)3 embedded in a CFRP composite has been 
demonstrated as being capable of repeated healing via microvascular channels (37).  
  
2. Materials and Methods  
2.1 Materials 
Ethyl phenylacetate (EPA, C6H5CH2C(O)OC2H5), urea (NH2CONH2), poly(ethylene-alt-maleic anhydride) 
(EMA, Mw=100,000–500,000, powder); resorcinol (C6H4-1,3-(OH)2), formaldehyde (37 wt% in H2O), 
ammonium chloride (NH4Cl) and scandium (III) triflate (Sc(OTf)3) were purchased from Sigma-Aldrich and 
used as received. Sodium hydroxide (NaOH) was purchased from Fisher Scientific. Commercial epoxy resin - 
EPON 828 was purchased from PolySciences, Inc. Carbon fibre/epoxy resin tape (SE 70) and adhesive resin 
film (SA 70) were sourced from Gurit, UK and also used as received.  
2.2 Methods  
Microencapsulation. Microcapsules containing epoxy resin and organic solvent were prepared by in-situ 
polymerisation in an oil-in-water emulsion (21). Briefly, 60 mL of water phase containing 1 wt% of emulsion 
stabilizer (EMA) was prepared in a round bottomed vessel and subsequently 1.25 g of urea, 0.125 g of 
Resorcinol and 0.125 g of ammonium chloride were added and dissolved. After that, the pH of the water phase 
was adjusted by dropwise addition of NaOH (≈0.2 N) to 3.10. Stirring speed was increased to 800 rpm and 30 
mL of measured oil phase was added dropwise. 3.16 g of formalin was added and the temperature was increased 
to 55°C. After 4 hours, the stirrer was stopped, and the microcapsule slurry was left in the water medium for 24 
hours at ambient temperature. Next, microcapsules were filtered in order to separate capsules with desired size. 
Capsules were vacuum filtered and rinsed a few times with ethanol/water. The isolated capsules were post 
heated at 55°C in an oven for 2 days. Yield of microcapsules was calculated relative to mass of used materials 
(Y%).  
Microcapsule analysis. Microcapsule diameter and size distribution was analysed by a Zeiss optical 
microscope AX10, Imager.M2 equipped with a video camera AxioCam.ICc 1. For the size distribution, image 
analysis software (ImageJ) was used. Mean diameter and size distribution were obtained from at least 500 
measurements of capsule diameter. Surface morphology analysis for dry microcapsules  
was performed with a scanning electron microscope JOEL SEM 5600LV. Thermal stability of microcapsules 
was determined using thermogravimetric analysis (TGA). Mass loss of microcapsules was recorded during non-
isotherm from 25 to 500°C and isothermal measurements at using a TA Instruments Q500 TGA. 
Composite manufacturing. Composites with embedded healing chemistries were manufactured using 
unidirectional carbon/epoxy resin tape (SE 70, Gurit UK) and adhesive resin film (SA 70, Gurit, UK) by 
standard hand-lay up technique (16 plies – 80 mm x 195 mm). Laminates after lay-up were vacuum bagged on 
an aluminium tool plate and consolidated according to the manufacturer’s recommendations (at 100°C for 100 
minutes) under vacuum of 660-710 mmHg. The artificially created damage region was filled with a resin paste 
(SA70 resin film) containing healing chemistries at the desired weight loading (Table 1). The filling paste was 
prepared by dispersion of dry capsules and/or catalyst at 65°C. Each panel was equipped with a release film at 
85 mm from the edge of specimens overlapping at minimum 500 µm of the resin pocket. The detailed 
configuration of the system is presented in the Figure 1. After curing, composite plates were removed from the 
vacuum bag and a 30 mm region from the panel front was grit blasted. Composite plates were then trimmed and 
cut into DCB specimens (20 mm x 175 mm). Piano hinges were bonded to the specimens at the pre-cracked end 
using Araldite 2014 structural adhesive and left at ambient temperature until fully cured.  
 
 Figure 1. CFRP double cantilever beam specimen (DCB) geometry adopted from ASTM standard test method 
5528-01 (38), containing artificially created damage region with embedded self-healing chemistries.  
 
Types of specimens and geometry. The double cantilever beam (DCB) tests specimens were used to quantify 
mode I recovery using manual and autonomous approaches to self-healing. The specimen geometry was adapted 
from the ASTM standard test method 5528-01 [38].  
Two types of control specimens were manufactured and tested in order to determine a benchmark of the 
composite fracture properties and the effect of embedded SA 70 (Gurit, UK) resin interleaf. The Control 1 
specimens, containing no additional interleaves, was used to determine the fracture properties of selected 
composite material (SE 70, Gurit, UK) and to determine a benchmark for mode I recovery using the resin 
formulation described in the literature (37). Specimens were fractured according to the standard test method (38) 
and manually injected with liquid resin – catalyst formulation. After self-healing processes, the specimens were 
retested using the same approach. The Control 2 (Figure 1) was used to determine the virgin fracture properties 
of the modified DCB geometry. This geometry was used in order to control the propagating crack from the non-
bonding insert to the end of resin pocket through the embedded microcapsules and catalyst particles. 
Subsequently, the epoxy microcapsules and catalyst particles were embedded in the interleaf at various 
combinations. The crack introduced during mode I DCB testing ruptures microcapsules causing release of liquid 
monomer and subsequent contact with embedded particles of Sc(OTf)3. The detailed test specimen’s 
configurations are summarised in Table 1. First, specimens containing literature loadings of microcapsules and 
the catalyst (9) were tested as the proof of concept for autonomic self-healing. The effect of microcapsules 
loading was determined at constant concentration of the catalyst (2.5wt%) and from 5.5 to 26 wt% of 
microcapsules. The effect of Sc(OTf)3 particles was determined later at constant loading of microcapsules (11 
wt%) and variable concentration of the catalyst ranging from 1 to 10 wt%. It should be noted here that the 
weight fraction of the catalyst and microcapsules was measured relatively to the resin used as filler in the resin 
pocket.  
 
 
 
Table 1. Designation of all tested DCB specimens and composition of interleaf resin present in the damage 
region.  
Specimen type 
Healing 
Mechanism 
Microcapsules size  
Epoxy 
Microcapsules 
(wt%)1 
Catalyst load 
(wt%)2 
Control 1 Manual - - - 
Control 2 - - - - 
Autonomous 
Autonomous 
20-450 26 2.5 
5.5wt_2.5wt% 
250-450 
5.5 2.5 
11wt_2.5wt% 11  2.5 
26wt_2.5wt% 26  2.5 
11wt_0.0wt% 11  0 
11wt_1.0wt% 11  1.0 
11wt_5.0wt% 11  5.0 
11wt_10wt% 11  10 
1, 2) - Microcapsules and catalyst weight loading calculated relatively to SA 70 epoxy resin used as the filler.  
 
Mode I DCB fracture toughness (strain energy release rate) tests and healing quantification. An 
electromechanical test machine (Shimadzu AGX-X) equipped with 1 kN load cell and a video camera was used 
in opening mode I interlaminar fracture tests for virgin and healed double cantilever beam tests specimens 
(DCB). Tests were performed in accordance to the ASTM 5528-01 standard method (38). Specimens were 
tested in crack opening mode at 3 mm/min displacement rate, from the release film to the end of interleave resin 
region containing microcapsules. After testing, specimens were unloaded, sealed and left at 80°C for 24 hours. 
Healed specimens were retested using the same methodology. 
The healing efficiency (η) was calculated from the ratio of the healed maximum peak load (PHealed) to the virgin 
maximum peak load (PVirgin).  𝜂 = 𝑃!"#$"%𝑃!"#$"% ∙ 100% 
Values of initial opening mode I interlaminar strain energy release rate (GIc) were determined for various 
specimens to demonstrate the effect of healing chemistries on the composite. The GIc values were calculated at 
the point of deviation from linearity on the load-displacement curves:  𝐺!" = 3𝑃𝛿2𝑏𝑎 
where P is the applied load at the onset of non-linearity, δ is the load point displacement, b and a are specimen 
average width and delamination length respectively.  
  
3. Results  
3.1 Microencapsulation  
Microcapsules containing the diglycidyl ether of bisphenol A were synthesized using in-situ polymerisation 
in an oil-in-water emulsion (39). Size distribution, corresponding scanning electron micrographs and results for 
thermal stability are presented in Figure 2.  
 
 
Figure 2. a) Size distribution of prepared poly(urea-formaldehyde) microcapsules containing 75wt% of epoxy 
resin (EPON 828) and 25wt% of organic solvent (Ethyl phenylacetate – EPA); b) corresponding SEM image; c) 
representative non-isothermal and d) isothermal TGA traces for the microcapsules. 
 
Microcapsules after synthesis exhibited a wide size distribution ranging from 20-420 microns in diameter 
(Figure 2a). The microencapsulation efficiency calculated according to the mass of used chemicals in the 
process resulted in satisfactory 77%. Enclosed scanning electron micrograph (Figure 2b) illustrate that the 
microcapsules have regular spherical shape and the shell wall is covered with rough polymeric layer of 
poly(urea-formaldehyde) (39). The thermal stability of microcapsules was determined using thermogravimetric 
analysis (TGA). The results of non – isothermal analysis indicated that microcapsules are stable to 170°C 
(Figure 2c). The first observed mass loss is associated with evaporation of ethyl phenylacetate (B.P. 229°C) 
released from microcapsules. When poly(urea-formaldehyde) decomposes, the organic solvent and epoxy resin 
are released and the organic solvent evaporates immediately. Increasing further temperature, a mass loss 
associated with the decomposition of DGEBA resin is observed. When the epoxy resin-organic solvent mixture 
is unprotected in polymeric shell, the increase of temperature and continues flow of purge gas (Nitrogen), cause 
evaporation of the ethyl phenylacetate at much lower temperature. It is calculated that the solvent content in the 
healing resin is 25.4% and the epoxy resin is 74.6%. In addition, analysing Figure 2d it is concluded that epoxy 
microcapsules are thermally stable when exposed to curing conditions of the selected carbon fibre/epoxy resin 
pre-preg material (SE70 Carbon/epoxy). A minor 2.5% mass loss calculated from the graph corresponds to 
water evaporation from the polymeric shell.  
3.2 Manual healing 
Blank DCB specimens were tested in order to determine a benchmark of mode I fracture toughness and self-
healing using the resin formulation described in the literature as the most promising for such application (9, 36, 
37). After the initial fracture tests, the DCB specimens were manually healed and retested using the same 
methodology. Healing was achieved by manual injection with the mixture containing 75wt% EPON 828 – 
25wt% Ethyl phenylacetate and 3.25 phr of solid state scandium (III) triflate. A typical load displacement curve 
illustrating pristine fracture behaviour and crack arrest is presented in Figure 3a. The average healing efficiency 
calculated from the difference of maximum peak loads (Pmax) is 52.5%. This low value is associated with the 
lack of non-repairable fibre bridging developed in pristine specimens. Figure 4. illustrates fracture surfaces of 
DCB specimens after the initial tests and after the manual repair. A cohesive debonding mode of injected and 
polymerised epoxy resin is observed which suggests that the strength of the interface between carbon fibres and 
the epoxy resin is higher than fracture strength of the resin. Detailed data for healing efficiency (η) and initial 
interlaminar fracture toughness (GIC) are summarized in Table 2.  
 
Figure 3. Typical load-displacement curves for virgin and healed a) control specimens type 1 containing no 
interleave resin and b) specimens containing 26 wt% of microcapsules and 2.5 wt% solid phase catalyst in the 
interleave.  
 
Figure 4. Fracture surfaces for control specimens type 1 a) after initial fracture tests and b) after manual repair 
and retest.  
200#μm## 200#μm##
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The data collected here indicate that the resin formulation described in the literature (36-37) is capable of 
successful restoration of mode I properties of the selected epoxy resin/carbon fibre material (SE70, Gurit, UK). 
In liquid phase, the healing agent has a low viscosity and long gel time allowing penetration and wetting of the 
fractured surfaces. In the solidified state, the epoxy resin is plasticised by the organic solvent (EPA) what results 
in increased fracture toughness that in non-modified resin. Such modification results in steady and progressive 
crack propagation for the manually healed DCB specimens as presented in Figure 3a.  
 
 
Figure 5. Artificially created resin-pocket in representative DCB specimens a) before and b) after the initial 
mode I fracture toughness test.  
3.3 Autonomous self-healing 
Autonomous self-healing was determined for a series of specimens containing microcapsules and catalyst in 
the interleave region (Figure 5). First, tests were performed for maximum load of microcapsules (26 wt%) and 
load of catalyst adapted from literature (2.5 wt%) (9). Figure 3b represents a typical load-displacement curve for 
virgin and healed DCB specimens. The observed crack arrest indicates that the chemistries embedded in the 
interleave region are active after composite manufacturing and polymerised healing agent bonds the fractured 
surfaces. However, the average self-healing efficiency id not exceeded 10% of the value of maximum load at the 
crack onset. Embedded healing chemistries caused substantial decrease in initial maximum load (Pmax) at crack 
onset and corresponding GIC values (Table 2). It indicates that microcapsules and catalyst have a detrimental 
effect on the proposed FRP composite. Figure 6 shows a representative fracture surface for Control 2 specimen 
revealing no features of crack arrest in the SA 70 epoxy resin. Surface morphology for autonomous specimens 
(Figure 7) illustrates ruptured microcapsules, catalyst particles and thin film created by polymerised epoxy 
healing agent covering the fracture surface. The excessive porosity created by liquid filled microcapsules was 
assumed to be responsible for such high decrease in materials virgin properties. Further work focused on 
optimisation of microcapsules size and catalyst load with the aim of increasing the self-healing rate and 
examining the effect of healing components on material performance.  
 
Figure 6. SEM image of DCB fracture surfaces of a specimen containing resin pocket and no microcapsules and 
catalyst dispersed in the damage region.  
  
Figure 7. a) Fracture morphology of a specimen containing 25 wt% microcapsules dispersed in polymeric 
matrix and 2.5 wt% of catalyst particles, b) image illustrating ruptured microcapsules at higher magnification 
and c) image illustrating undissolved catalyst particles covered in thin film of epoxy healing agent.  
3.3.1 The effect of microcapsules load  
Self-healing was determined for specimens containing variable concentrations of microcapsules dispersed in 
the composite interleave (Table 1). It was assumed that the low healing efficiency is associated with low 
bonding area in the proof of the concept study (see entry “Autonomous” in Table 2). Loading of microcapsules 
was calculated according to the mass of SA 70 resin used in the manufacturing of each separate panel and 
corresponds to 5.5, 11 and 26 wt%. Here, the diameter of microcapsules was limited to 250-420 µm in order to 
ensure their full rupture by a propagating crack and to decrease the induced porosity. Fracture morphology 
illustrating microcapsule distribution in the damage zone is presented in Figure 8. Table 2 summarises results, 
which indicate that recovery of mode I is independent of microcapsule loading. Moreover, an average 12% self-
healing was observed for all test specimens. It indicates that volume of encapsulated liquid monomer is enough 
to cover the fracture surface and bridge them after polymerisation. It was assumed that the low self-healing rate 
is a result of low crosslinking density in the newly formed epoxy resin. Increasing the number of polymerisation 
centres could result in tougher polymer that should bond the fractured surfaces more effectively. Additionally, a 
minimum decrease in initial fracture toughness (GIC) was observed between specimens without microcapsules 
(Control 2) and containing 11 wt% of microcapsules (250-420 µm). Reducing the number of microcapsules in 
the damage zone, an increase of the maximum peak load (Pmax) and calculated fracture toughness (GIC) is 
observed (Table 2). Reducing the number of the stress concentration regions, a 16N increase of Pmax and 251 
J/m2 of GIC is calculated bringing the value close to Control 2 specimen. These facts suggest that the size and 
size distribution of microcapsules can be tailored in FRP composites to deliver healing functionality with 
minimum detrimental effect. In further work, DCB specimens were prepared at this microcapsules 
concentration, the work aimed to increase the self-healing rate by manipulating the catalyst concentration in the 
system.  
 
Figure 8. SEM images of surface morphologies for DCB specimens containing variable loading of 
microcapsules embedded in the interleave region; a) 5.5 wt%, b) 11 wt% and c) 26 wt%; at constant load of 
catalyst (2.5 wt%).  
 
 Figure 9. a) Self-healing efficiency and b) initial fracture toughness (GIC) for specimens containing variable 
volume of self-healing phase using microcapsules within 250-450 µm range. 
 
Table 2. Summary of healing efficiency (η) and initial fracture toughness (GIC) in dependence on SH agent 
load/volume in the damage region.  
Designation 
Vol 
% 
Capsules 
size (µm) 
Initial Load 
PVirgin (N) 
Healed Load 
PHealed (N) 
η (%) 
Initial GIC 
(J·m
-2
) 
Temp 
Manual - - 47.0±1.3 24.7±4.3 52.5±8.9 413±19 
80°C 
Autonomous 26 20-450 57.2±10.6 5.5±1.5 9.9±3.5 746±97 
Control 2 - - 81.0±6.4 - - 1371±224 
5.5wt_2.5wt% 5.5 250-420 71.0±4.3 7.8±2.0 10.7±2.0 1076±161 
11wt_2.5wt% 11 250-420 77.0±9.1 8.6±1.8 11.3±3.3 1311±326 
26wt_2.5wt% 26 250-420 68.4±3.5 6.8±1.7 11.8±2.5 997±86 
 
3.3.2 The effect of Sc(OTf)3 concentration  
To increase the self-healing rate and to understand the effect of catalyst particles on initial fracture 
properties, a series of specimens containing variable loadings of Sc(OTf)3 at constant concentration of 
microcapsules (11 wt%) were prepared and tested. Specimens were healed for 48 hours in order to ensure full 
crosslinking of released healing agent. Table 3 summarises the test results where Figure 10 presents a series of 
results collected for the specimens containing 0, 1, 5 and 10 wt% of Sc(OTf)3. The maximum 44% of self-
healing was obtained at maximum catalyst loading (10wt%) and decreases with lower load of the catalyst. In 
addition, an average of 14% recovery was obtained for specimens containing no catalyst particles, indicating the 
presence of solvent promoted self-healing (15). It is concluded that the increase of healing rate is associated 
with a substantial decrease in initial fracture properties. Results in Table 3 suggest that the initial fracture 
toughness (GIC) decreased to 301 J/m2, which is close to that observed for Control 1 specimens containing no 
resin interleave– 413 J/m2 (Table 2). The values of the maximum peak load (Pmax) for all healed specimens 
remains in the same range (13.2 – 16.0 N) indicating that the presence of catalyst has no beneficial effect on the 
mode I recovery. Figure 11. illustrates altered fracture surfaces containing 1, 5 and 10 wt% of the catalyst 
particles. The fracture morphology containing only microcapsules is illustrated in Figure 12.  
 Figure 10 a) Self-healing efficiency and b) initial fracture toughness (GIC) for specimens containing variable 
weight of Sc(OTf)3 at 11 wt% microcapsules (250-450 µm range). 
 
Table 3. Summary of healing efficiency (η) and fracture toughness (GIC) in dependence on Sc(OTf)3 load 
dispersed in the interleave region. 
Designation 
Vol 
% 
Capsules size 
(µm) 
Initial 
Load  
PVirgin (N) 
Healed 
Load  
PHealed (N) 
η (%) 
Initial GIC 
(J·m
-2
) 
Healing 
Temp 
Control 2 - - 81.0±6.4 - - 1371±224 
80°C 
11wt_0.0wt% 10 250-420 83.1±5.3 13.2±1.3 14.2±5.7 1399±186 
11wt_1.0wt% 10 250-420 73.4±9.5 12.7±3.2 17.7±6.1 1184±158 
11wt_5.0wt% 10 250-420 59.4±6.9 14.0±0.5 23.8±3.5 777±170 
11wt_10wt% 10 250-420 38.4±7.8 15.8±2.0 43.6±15.0 301±99 
 
 
Figure 11. Fracture morphologies of DCB samples containing 11 wt% of capsules and a) 1 wt% catalyst, b) 5 
wt% catalyst and 10 wt% catalyst.  
 
 Figure 12. SEM image of DCB specimen containing 11 wt % of microcapsules (250-450 µm range) in the 
damage region.  
4. Discussion  
An autonomous self-healing based on epoxy resin filled microcapsules and solid phase catalyst is 
demonstrated in a high performance carbon fibre reinforced polymer composite (cured at 100°C for 100 
minutes) and examined for its performance. The crack arrests observed on the load-displacement curves (Figure 
2) indicate that the released epoxy resin undergoes polymerisation after contact with dispersed catalyst particles 
and bonds the fracture surfaces. The SEM analysis (Figure 7) revealed ruptured microcapsules, residual catalyst 
particles and thin film of epoxy healing agent covering the fracture surfaces. It was found that mode I recovery 
is dependent on the catalyst loading and reached 44% maximum (comparable to 52% for manually healed). 
However, this increase is associated with substantial (3x) decrease in initial fracture toughness (GIC) and the 
maximum load at the crack onset (Pmax). Nevertheless, it is demonstrated that concentration of microcapsules 
embedded in the damage region can be tailored to achieve self-healing with minimal detrimental effect on the 
structure. Moreover, reducing the number of microcapsules by removing the samples with size smaller than 250 
µm, an increase in maximum peak load (Pmax) and fracture toughness (GIC) is observed. It suggest that the wide 
range of microcapsules’ diameter generates excessive porosity that impedes the properties of the host material. 
Low healing efficiency was associated with low cross-linking rate initiated by the chosen catalytic curing agent 
(Sc(OTf)3) and its presence as a solid. Attempts to increase the self-healing rate by tailoring the catalyst loading 
resulted in decrease further decrease of the composite fracture properties without any gain of mode I recovery.  
While the concentration of microcapsules has no effect on self-healing efficiency (Table 2), their higher 
concentration caused a decrease in the host material’s initial fracture toughness and change in fracture 
morphology. This trend was already observed in epoxy based polymers (9, 10, 22), adhesives (40) and woven 
composites (5, 12, 19, 23), where inclusion of microcapsules always gave rise to a decrease in material 
attributes. Microcapsules and catalyst particles are considered as voids, creating discontinuities in the host 
polymer and acting as stress concentrations. To minimise the effect, microcapsule diameter was restricted to 
250-420 µm which resulted in average GIC close to virgin at 11 wt% of microcapsules (Figure 9). In addition, 
inclusion of the interleave region filled with capsules resulted in a 3x increase in G1c when compared to blank 
specimens (Table 2). It is associated with the presence of bulk epoxy resin at the crack initiation point. In blank 
specimens the crack is initiated at the weak interface between the carbon fiber and the polymeric matrix. In the 
developed structure, the crack is initiated in a bulk epoxy resin (SA 70) that exhibited much higher fracture 
toughness than the strength of the interface.  
To increase the self-healing efficiency, a series of specimens containing higher concentrations of solid 
phase catalyst were prepared and tested. While the healing efficiency increased with catalyst concentration, a 
substantial reduction in initial fracture toughness was recorded (Figure 10). The maximum healing efficiency 
(44%) reached values for control specimens repaired by manual injection (52%). Similarly, observed reduction 
of fracture properties is associated with excessive presence of voids created by scandium (III) triflate particles in 
the fracture planes. It is illustrated in Figures 11b and 11c where microcapsules are surrounded by Sc(OTf)3 
particles that significantly alter the fracture morphology. In general, undissolved catalyst particles, their 
detrimental effect on material attributes, and little beneficial effect on healing rate, suggest that application of a 
microcapsule – solid phase catalyst system in high performance FRP composite structures is questionable.  
In summary, an autonomous self-healing is demonstrated and assessed for its performance in a 
unidirectional FRP composite structure. The work shows that microcapsule healing can be adapted and 
optimised in unidirectional FRP composite materials. However, the investigated system, which relies on a 
distribution of microcapsules and a solid phase catalyst, is detrimental to the FRP composite. Interlaminar 
fracture toughness (GIC) is severely affected by presence of both healing components. The low solubility of 
scandium (III) triflate in liquid resin, it’s premature consumption, the detrimental effect on the host structure and 
little beneficial effect on healing efficiency were identified as substantial limitations for commercialisation. 
Therefore, an alternative system based on a single component healing system or integrated double capsules 
should be considered for such an application. A microcapsule – catalyst system could be considered as an 
adhesive, where inhibited reactivity is required for extended period of time. Nevertheless, it has been 
demonstrated that microcapsule self-healing can be achieved in a unidirectional FRP composite cured at high 
temperature (100°C) and located in regions of possible damages.  
5. Conclusions  
An autonomous self-healing system was demonstrated in a high performance unidirectional FRP composite 
using epoxy resin filled microcapsules and a solid phase catalyst (Sc(OTf)3). Healing efficiency and effect of 
microcapsules on the structure was assessed using mode I fracture toughness testing. A maximum of 52% and 
44% recovery was obtained for specimens healed manually and autonomously, respectively. However, inclusion 
of resin interleaves and healing chemistries in laminates have a detrimental effect on their performance. It has 
been demonstrated that amount of both healing components can be tailored to avoid a decrease in material 
performance.  
Furthermore, the application of a solid phase catalyst remained questionable due to its low efficiency in the 
polymerisation of encapsulated epoxy healing agent. A similar crack arrest rate after healing was obtained for 
specimens containing only microcapsules (12%). Nevertheless, autonomous self-healing was achieved in a 
structural component based on commercial epoxy resin/carbon fibre tape (SE70 Carbon, Gurit, UK). It is also 
demonstrated that the healing chemistry can be located in regions of possible damage in composite components.  
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